Coronary Artery Calcium Scoring in 2026: Still Powerful, but Only When Used for the Right Patient

Coronary Artery Calcium Scoring in 2026: Still Powerful, but Only When Used for the Right Patient Review Key Takeaways Coronary artery calcium (CAC) scoring continues to occupy an important role in contemporary cardiovascular risk assessment and remains far from obsolete. Although advances in cardiovascular imaging, biomarker testing, and

Drug Preferences Among Patients And Physicians For Diagnosed Dyslipidemia

Drug Preferences Among Patients And Physicians For Diagnosed Dyslipidemia Overview The study focused on evaluating patient and physician drug preferences regarding lipid-lowering drugs, particularly proprotein convertase subtilisin/kexin type 9 inhibitors, as an alternative to statins for dyslipidemia treatment. Employing an online discrete choice experiment (DCE), the research aimed to ascertain the relative

Coronary Artery Calcium Scoring in 2026: Still Powerful, but Only When Used for the Right Patient